If You Only Buy 1 Pot Stock, This Should Be It

With a partnership with Molson Coors (TSX:TPX.B)(NYSE:TAP), and more on the way, this pot stock should be your number one investment.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Pot stocks had an amazing 2018. Several upstarts became multi-billion dollar giants. The cannabis industry saw valuations double, triple, and then quadruple in a matter of months.

Those days are long over. In 2019, the industry entered its first bear market. Any hopes of a recovery in 2020 were dashed by the coronavirus pandemic.

Today, valuations are at rock bottom. No one is willing to touch pot stocks. This is a time of opportunity for investors looking to strike it rich.

Just choose carefully. Not all cannabis firms are equal. Certain stocks have significantly more upside.

Look for this

Don’t trust all pot stocks. Only a small handful have what it takes to create immense shareholder value. It’s like the tech boom of the late 1990s. The vast majority of tech stocks went bankrupt during that period, but a few become multi-trillion dollar businesses.

Massive profits can be had if you choose carefully. But which stocks should you choose? There’s one filter you should apply to all candidates: will it be commoditized?

When the cannabis boom first began in 2018, investors thought they were witnessing another gold rush. What they got was carrots and potatoes. Not literal carrots and potatoes, but the equivalent.

Everyone thought cannabis was gold, but it turns out that it’s similar to just about any other cash crop. Long term, supply and demand will ravish pricing as the product becomes a commodity.

The best-performing pot stocks will figure out how to transform their cannabis production into something other than a commodity. They must take a page from the book of Coca-Cola.

Cokes sells commodities, mainly sugar and water. But somehow, they figured out how to get customers to pay 50 times the price of the underlying ingredients. That’s the magic of branding, and one cannabis producer has cracked the code.

Pick this pot stock

Hexo (TSX:HEXO)(NYSE:HEXO) stock is your best bet for big profits in the cannabis space. That’s because it figured out how to brand raw marijuana.

Its competitive advantage is that it partners with existing brands to co-develop products. It doesn’t need to create its own brands from scratch, but rather leverages brands that consumers already know and love.

“For example, Hexo has a partnership with Molson Coors (TSX:TPX.B)(NYSE:TAP) to co-produce THC-infused beverages,” I wrote earlier this month. “Hexo provides the marijuana expertise, while Molson lends its globally-recognized brand.”

This partnership alone could make this pot stock a long-term winner. Hexo’s market cap is just $375 million, but the potential sales from a Molson-partnered product could exceed $100 million, especially consider both firms just agreed to expand the deal to international markets.

Hexo hopes to replicate this partnership in other categories like cosmetics and sleep aids. If that happens, it skips right to the front of the line for demand. Consumers will likely pick its products first over a product from an unknown cannabis startup.

You can make big gains with pot stocks, but only if you choose carefully. Hexo has assembled the right team and business model to become one of the fastest-growing producers over the next 12 months.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

The Motley Fool recommends HEXO. and HEXO. Fool contributor Ryan Vanzo has no position in any stocks mentioned.

More on Coronavirus

little girl in pilot costume playing and dreaming of flying over the sky
Coronavirus

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food
Coronavirus

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane
Coronavirus

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane
Coronavirus

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.
Coronavirus

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »

sad concerned deep in thought
Coronavirus

Here’s Why I Just Bought WELL Health Stock

WELL Health stock (TSX:WELL) may be a healthcare stock and a tech stock, but don't let that keep you from…

Read more »

healthcare pharma
Coronavirus

WELL Stock: The Safe Stock Investors Can’t Afford to Ignore

WELL stock (TSX:WELL) fell 68% from peak to trough, and yet there's no good reason as to why. So now…

Read more »